Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does BUPRENORPHINE Cause Muscular weakness? 463 Reports in FDA Database

Grow Your Own Natural Pharmacy at Home

Medicinal Garden Kit — 10 healing herbs, 4,818 seeds + step-by-step guide.

Get the Kit

According to the FDA Adverse Event Reporting System (FAERS), 463 reports of Muscular weakness have been filed in association with BUPRENORPHINE (Buprenorphine and Naloxone). This represents 0.6% of all adverse event reports for BUPRENORPHINE.

463
Reports of Muscular weakness with BUPRENORPHINE
0.6%
of all BUPRENORPHINE reports
358
Deaths
325
Hospitalizations

How Dangerous Is Muscular weakness From BUPRENORPHINE?

Of the 463 reports, 358 (77.3%) resulted in death, 325 (70.2%) required hospitalization, and 298 (64.4%) were considered life-threatening.

Is Muscular weakness Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for BUPRENORPHINE. However, 463 reports have been filed with the FAERS database.

What Other Side Effects Does BUPRENORPHINE Cause?

Drug dependence (16,730) Overdose (13,977) Death (13,604) Toxicity to various agents (10,906) Pain (8,219) Drug withdrawal syndrome (7,149) Emotional distress (6,159) Drug abuse (4,344) Drug ineffective (4,261) Dependence (3,184)

What Other Drugs Cause Muscular weakness?

ADALIMUMAB (3,605) METHOTREXATE (2,813) RITUXIMAB (2,621) ATORVASTATIN (2,494) PREDNISONE (2,236) ETANERCEPT (2,207) DALFAMPRIDINE (1,916) TOCILIZUMAB (1,790) FINGOLIMOD (1,769) SECUKINUMAB (1,747)

Which BUPRENORPHINE Alternatives Have Lower Muscular weakness Risk?

BUPRENORPHINE vs BUPRENORPHINE\NALOXONE BUPRENORPHINE vs BUPROPION BUPRENORPHINE vs BUPROPION HYDROBROMIDE BUPRENORPHINE vs BUPROPION\DEXTROMETHORPHAN HYDROBROMIDE BUPRENORPHINE vs BUPROPION\NALTREXONE

Related Pages

BUPRENORPHINE Full Profile All Muscular weakness Reports All Drugs Causing Muscular weakness BUPRENORPHINE Demographics